Jia Weiping

June 2, 2022 Share:

Dr. Jia is an academician of the Chinese Academy of Engineering, member of the Chinese Academy of Medical Sciences, director of the Shanghai Diabetes Institute, director of the National office for primary diabetes care, and chief editor of the Chinese Journal of Internal Medicine. She has published over 300 original articles as first and/or corresponding authors in journals, including BMJ, Lancet Diabetes Endocrinol, Cell Metab, Nat Biotechnol, Sci Transl Med, Diabetes, Diabetes Care, J Hepatol, etc. She has been awarded the national science and technology progress prizes, the provincial science and technology progress prizes, the Xiaoren Pan distinguished research prize for epidemiology of diabetes in Asia, the Ho Leung Ho Lee Foundation science and technology prize, and the Tan Jiazhen life science prize, etc. 

Her research achievements include the followings: Develop genetic models for people with type 2 diabetes, to early detect and warning high-risk people with diabetes among Chinese. Establish new diagnostic standards for abdominal obesity among Chinese, and continuous glucose monitoring standards globally, to promote the use of new personalized treatment technologies. Develop a hospital-community integrated management model for diabetes care, and a deep learning system for detecting diabetic complications, to promote the comprehensive diabetes prevention, treatment and management system in primary care. The Lancet Diabetes Endocrinol remarked, “Jia’s work is remarkable in integrating the worlds of specialty care with community health centres. This and her work integrating genetics with clinical care reflect her early interest in engineering.” The president of the American Endocrine Society remarked, “Professor Jia and her colleagues have been international leaders in the use of continuous glucose monitoring standards.”